Background/Aims: Gene-dietary pattern interactions may contribute to the determination of a susceptibility to metabolic syndrome (MetS). The aim of this study was to evaluate the potential interactions of dietary patterns with the common genetic variant of APOC3 in relation to MetS in adults. Methods: In this individual matched nested case-control study, 755 MetS subjects and 755 controls were selected from among participants in the Tehran Lipid and Glucose Study. Dietary patterns were determined by factor analysis. APOC3 3238C>G rs5128 was genotyped by polymerase chain reaction and restriction fragment length polymorphism. Results: Fat-sweet, healthy and Western dietary patterns (WDP) were extracted from the data. In the joint analysis, the associations of the WDP and APOC3 rs5128 with MetS risk tended to be dependent on APOC3 3238C>G gene variants (p for interaction = 0.009) in women. The MetS risk was increased in women with the CC genotype with increasing tertiles of WDP scores compared with women with the CG + GG genotype, whose MetS risk was decreased with increasing tertiles of WDP scores. In addition, we found that intakes of fast food, salty snacks and soft drinks showed significant interactions with the rs5128 genotypes in relation to MetS risk (p for interactions <0.05). Conclusion: The results obtained demonstrate a diet-gene interaction between APOC3 rs5128 polymorphism and the WDP in relation to MetS risk.

Keywords:
Dietary patterns, Genetic polymorphisms, Metabolic syndrome
1.
Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005;365:1415-1428.
2.
Hadaegh F, Shafiee G, Ghasemi A, Sarbakhsh P, Azizi F: Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2010;87:342-347.
3.
Hadaegh F, Zabetian A, Khalili D, Safarkhani M, Philip TJW, Azizi F: A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran. J Epidemiol Community Health 2012;66:427-432.
4.
Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, Tan CE: Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 2007;16:362-367.
5.
Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, Tohidi M: Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors. PLoS One 2013;8:e76304.
6.
Phillips CM: Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients 2013;5:32-57.
7.
Brown S, Ordovas JM, Campos H: Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins. Atherosclerosis 2003;170:307-313.
8.
Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F, Girelli D, Friso S, Pignatti PF, Corrocher R: Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 2003;44:2374-2381.
9.
Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJ, Connelly PW, Huff MW, Hegele RA: Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample. BMC Med Genet 2007;8:80.
10.
Martinez-Gonzalez MA, Martin-Calvo N: The major European dietary patterns and metabolic syndrome. Rev Endocr Metab Disord 2013;14:265-271.
11.
Baxter AJ, Coyne T, McClintock C: Dietary patterns and metabolic syndrome: a review of epidemiologic evidence. Asia Pac J Clin Nutr 2006;15:134-142.
12.
Imamura F, Lichtenstein AH, Dallal GE, Meigs JB, Jacques PF: Generalizability of dietary patterns associated with incidence of type 2 diabetes mellitus. Am J Clin Nutr 2009;90:1075-1083.
13.
Garcia-Rios A, Perez-Martinez P, Delgado-Lista J, Lopez-Miranda J, Perez-Jimenez F: Nutrigenetics of the lipoprotein metabolism. Mol Nutr Food Res 2012;56:171-183.
14.
Baylin A, Deka R, Tuitele J, Viali S, Weeks DE, McGarvey ST: INSIG2 variants, dietary patterns and metabolic risk in Samoa. Eur J Clin Nutr 2013;67:101-107.
15.
Yap RW, Shidoji Y, Hon WM, Masaki M: Association and interaction between dietary pattern and VEGF receptor-2 (VEGFR2) gene polymorphisms on blood lipids in Chinese Malaysian and Japanese adults. Asia Pac J Clin Nutr 2012;21:302-311.
16.
Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S: Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009;10:5.
17.
McCrory MA, Hajduk CL, Roberts SB: Procedures for screening out inaccurate reports of dietary energy intake. Public Health Nutr 2002;5:873-882.
18.
Esfahani FH, Asghari G, Mirmiran P, Azizi F: Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol 2010;20:150-158.
19.
Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F: Reliability and relative validity of an FFQ for nutrients in the Tehran Lipid and Glucose Study. Public Health Nutr 2010;13:654-662.
20.
Hosseini-Esfahani F, Jessri M, Mirmiran P, Bastan S, Azizi F: Adherence to dietary recommendations and risk of metabolic syndrome: Tehran Lipid and Glucose Study. Metabolism 2010;59:1833-1842.
21.
Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-S504.
22.
Kriska AM, Knowler WC, LaPorte RE, Drash AL, Wing RR, Blair SN, Bennett PH, Kuller LH: Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 1990;13:401-411.
23.
Momenan AA, Delshad M, Sarbazi N, Rezaei Ghaleh N, Ghanbarian A, Azizi F: Reliability and validity of the Modifiable Activity Questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med 2012;15:279-282.
24.
Daneshpour MS, Faam B, Mansournia MA, Hedayati M, Halalkhor S, Mesbah-Namin SA, Shojaei S, Zarkesh M, Azizi F: Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran Lipid and Glucose Study. Endocrine 2012;41:103-110.
25.
Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML: Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 2000;29:52, 54.
26.
Tas S: Strong association of a single nucleotide substitution in the 3′-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs. Clin Chem 1989;35:256-259.
27.
Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, Mirmiran P, Zabetian A, Mehrabi Y, Kelishadi R, Aghajani H: Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med 2010;13:426-428.
28.
Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA: Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol 2004;24:e19-e24.
29.
Hosseini-Esfahani F, Djazaieri SA, Mirmiran P, Mehrabi Y, Azizi F: Which food patterns are predictors of obesity in Tehranian adults? J Nutr Educ Behav 2012;44:564-573.
30.
Denova-Gutierrez E, Castanon S, Talavera JO, Gallegos-Carrillo K, Flores M, Dosamantes-Carrasco D, Willett WC, Salmeron J: Dietary patterns are associated with metabolic syndrome in an urban Mexican population. J Nutr 2010;140:1855-1863.
31.
Bahadoran Z, Mirmiran P, Hosseini-Esfahani F, Azizi F: Fast food consumption and the risk of metabolic syndrome after 3 years of follow-up: Tehran Lipid and Glucose Study. Eur J Clin Nutr 2013;67:1303-1309.
32.
Bhanushali AA, Das BR: Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians. J Community Genet 2010;1:139-148.
33.
Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA, Humphries SE: Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002;11:3039-3046.
34.
Hallman DM, Srinivasan SR, Chen W, Boerwinkle E, Berenson GS: Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Metabolism 2006;55:1574-1581.
35.
Lopez-Miranda J, Jansen S, Ordovas JM, Salas J, Marin C, Castro P, Ostos MA, Cruz G, Lopez-Segura F, Blanco A, Jimenez-Pereperez J, Perez-Jimenez F: Influence of the SstI polymorphism at the apolipoprotein C-III gene locus on the plasma low-density-lipoprotein-cholesterol response to dietary monounsaturated fat. Am J Clin Nutr 1997;66:97-103.
36.
de Andrade FM, Bulhoes AC, Maluf SW, Schuch JB, Voigt F, Lucatelli JF, Barros AC, Hutz MH: The influence of nutrigenetics on the lipid profile: interaction between genes and dietary habits. Biochem Genet 2010;48:342-355.
37.
Ordovas JM: Gender, a significant factor in the cross talk between genes, environment, and health. Gend Med 2007;4(suppl B):S111-S122.
38.
Qi L, Cornelis MC, Zhang C, van Dam RM, Hu FB: Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men. Am J Clin Nutr 2009;89:1453-1458.
39.
Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F: Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr 2012;108:1109-1117.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.